Nicolas Kong

Regulatory news: Nulibry (fosdenopterin) approved to reduce the risk of mortality in patients with molybdenum cofactor deficiency type A: FDA approval summary

J. Filie, Hylton V. Joffe, Sheila Farrell, 2021, Journal of inherited metabolic disease.